Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 741,375 $ 1,026,065
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 102,403 101,938
Loss on extinguishment of debt 0 13,286
Unrealized foreign exchange loss and other 9,970 1,783
Asset impairment charges 0 9,156
Disposal of non-controlling interest 0 8,270
Stock-based compensation expense 48,772 34,982
Gain on sale of business 0 (29,687)
Deferred income taxes (71,322) (156,226)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable 107,018 (55,073)
Inventories (138,419) (265,530)
Other assets (7,520) 45,637
Accounts payable 8,345 36,472
Deferred system revenue 14,057 (60,492)
Deferred service revenue 5,901 (12,411)
Other liabilities 63,160 313,375
Net cash provided by operating activities 883,740 1,011,545
Cash flows from investing activities:    
Net proceeds from sale of business 0 75,358
Business acquisitions, net of cash acquired 0 (27,144)
Capital expenditures (68,045) (84,352)
Purchases of available-for-sale securities (530,842) (256,793)
Proceeds from sale of available-for-sale securities 7,983 26,608
Proceeds from maturity of available-for-sale securities 201,149 211,465
Purchases of trading securities (49,958) (19,512)
Proceeds from sale of trading securities 48,042 19,875
Proceeds from other investments 0 1,020
Net cash used in investing activities (391,671) (53,475)
Cash flows from financing activities:    
Payment of debt issuance costs 0 (6,515)
Proceeds from revolving credit facility 0 300,000
Repayment of debt 0 (662,250)
Common stock repurchases (455,412) (89,846)
Payment of dividends to stockholders (181,507) (187,984)
Issuance of common stock 0 115
Tax withholding payments related to vested and released restricted stock units (68,237) (54,952)
Purchase of non-controlling interest 0 (4,295)
Net cash used in financing activities (705,156) (705,727)
Effect of exchange rate changes on cash and cash equivalents (3,208) (17,971)
Net increase (decrease) in cash and cash equivalents (216,295) 234,372
Cash and cash equivalents at beginning of period 1,927,865 1,584,908
Cash and cash equivalents at end of period 1,711,570 1,819,280
Supplemental cash flow disclosures:    
Income taxes paid, net 99,388 101,061
Interest paid 113,236 44,216
Non-cash activities:    
Contingent consideration payable - financing activities (920) 145
Dividends payable - financing activities 1,853 1,942
Unsettled common stock repurchase - financing activities 11,000 0
Accrued purchases of land, property and equipment - investing activities $ 22,729 $ 34,027